QuantuMDx Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 71

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $9.9M

  • Investors
  • 11

QuantuMDx General Information

Description

Developer of a point-of-care molecular diagnostic system designed to provide rapid, multiplexed testing for infectious diseases. The company's device uses sophisticated software algorithms and PCR technology to deliver clear results for sexually transmitted infections, respiratory viruses, and antimicrobial resistance, enabling healthcare providers to make targeted treatment decisions at the point of care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Lugano Building
  • 57 Melbourne Street
  • Newcastle Upon Tyne NE1 2JQ
  • England, United Kingdom
+44 0870
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Lugano Building
  • 57 Melbourne Street
  • Newcastle Upon Tyne NE1 2JQ
  • England, United Kingdom
+44 0870

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

QuantuMDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 23-Nov-2022 $9.9M Completed Generating Revenue
10. Later Stage VC 21-Oct-2021 Completed Generating Revenue
9. Later Stage VC 27-Jan-2020 Completed Generating Revenue
8. Later Stage VC 25-Jan-2019 Completed Generating Revenue
7. Later Stage VC 01-Dec-2017 Completed Generating Revenue
6. Later Stage VC 14-Dec-2016 Completed Startup
5. Later Stage VC 22-Dec-2015 Completed Startup
4. Angel (individual) 08-Dec-2014 Completed Startup
3. Product Crowdfunding 12-Feb-2014 $18.1K Completed Startup
2. Grant 17-Oct-2013 $1.6M Completed Startup
To view QuantuMDx’s complete valuation and funding history, request access »

QuantuMDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 16,026 $0.011620 $339.8 $339.8 1x $339.8 3.7%
Ordinary 35,821 $0.011620 $280.44 $280.44 1x $280.44 8.27%
To view QuantuMDx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

QuantuMDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a point-of-care molecular diagnostic system designed to provide rapid, multiplexed testing for infectious d
Diagnostic Equipment
Newcastle Upon Tyne, United Kingdom
71 As of 2025

Lausanne, Switzerland
 

Uppsala, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

QuantuMDx Competitors (29)

One of QuantuMDx’s 29 competitors is Abionic, a Venture Capital-Backed company based in Lausanne, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abionic Venture Capital-Backed Lausanne, Switzerland
Q-linea Formerly VC-backed Uppsala, Sweden
Vela Diagnostics Corporate Backed or Acquired Singapore, Singapore
BioFire Venture Capital-Backed Salt Lake City, UT
Biocartis Venture Capital-Backed Mechelen, Belgium
You’re viewing 5 of 29 competitors. Get the full list »

QuantuMDx Patents

QuantuMDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026229144-A1 Droplet collector and microfluidic devices containing the same Pending 28-Apr-2025
GB-202506398-D0 Droplet collector and miucrofluidic devices containing the same Pending 28-Apr-2025
EP-4808691-A1 Flow regulators for the control of liquid fronts in microfluidic structures Pending 16-Nov-2023
GB-2636565-A Flow regulators for the control of liquid fronts in microfluidic structures Active 16-Nov-2023
GB-2636565-B Flow regulators for the control of liquid fronts in microfluidic structures Active 16-Nov-2023 B01L3/50273
To view QuantuMDx’s complete patent history, request access »

QuantuMDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

QuantuMDx Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Astrid Hill Investment Venture Capital Minority
British Business Bank Lender/Debt Provider Minority
Vita Spring IVD Fund Venture Capital Minority
Adjuvo Venture Capital Minority
3B Future Health Fund Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

QuantuMDx Acquisitions (1)

QuantuMDx’s most recent deal was a Merger/Acquisition with Northgene. The deal was made on 01-Mar-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Northgene 01-Mar-2013 Merger/Acquisition Laboratory Services (Healthcare)
To view QuantuMDx’s complete acquisitions history, request access »

QuantuMDx Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Northgene Deeside, United Kingdom 1994

QuantuMDx FAQs

  • When was QuantuMDx founded?

    QuantuMDx was founded in 2008.

  • Where is QuantuMDx headquartered?

    QuantuMDx is headquartered in Newcastle Upon Tyne, United Kingdom.

  • What is the size of QuantuMDx?

    QuantuMDx has 71 total employees.

  • What industry is QuantuMDx in?

    QuantuMDx’s primary industry is Diagnostic Equipment.

  • Is QuantuMDx a private or public company?

    QuantuMDx is a Private company.

  • What is the current valuation of QuantuMDx?

    The current valuation of QuantuMDx is .

  • What is QuantuMDx’s current revenue?

    The current revenue for QuantuMDx is .

  • How much funding has QuantuMDx raised over time?

    QuantuMDx has raised $112M.

  • Who are QuantuMDx’s investors?

    Astrid Hill Investment, British Business Bank, Vita Spring IVD Fund, Adjuvo, and 3B Future Health Fund are 5 of 11 investors who have invested in QuantuMDx.

  • Who are QuantuMDx’s competitors?

    Abionic, Q-linea, Vela Diagnostics, BioFire, and Biocartis are some of the 29 competitors of QuantuMDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process